Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Coa LL
,
Abreu TF
,
Tashima AK
,
Green J
,
Pascon RC
,
Vallim MA
,
Machado-Jr J
.
???displayArticle.abstract???
The serine-threonine kinase AKT/PKB is a critical regulator of various essential cellular processes, and dysregulation of AKT has been implicated in many diseases, including cancer. Despite AKT action is known to function mainly in the cytoplasm, AKT has been reported to translocate to the nucleus. However, very little is known about the mechanism required for the nuclear import of AKT as well as its function in this cellular compartment. In the present study, we characterized the presence of endogenous nuclear AKT in human melanoma cells and addressed the possible role of AKT by exploring its potential association with key interaction nuclear partners. Confocal and Western blot analyses showed that both phosphorylated and non-phosphorylated forms of AKT are present in melanoma cells nuclei. Using mass spectrometry in combination with protein-crosslinking and co-immunoprecipitation, we identified a series of putative protein partners of nuclear AKT, including heterogeneous nuclear ribonucleoprotein (hnRNP), cytoskeleton proteins β-actin, γ-actin, β-actin-like 2 and vimentin. Confocal microscopy and biochemical analyses validated β-actin as a new nuclear AKT-interacting partner. Cofilin and active RNA Polymerase II, two proteins that have been described to interact and work in concert with nuclear actin in transcription regulation, were also found associated with nuclear AKT. Overall, the present study uncovered a yet unrecognized nuclear coupling of AKT and provides insights into the involvement of AKT in the interaction network of nuclear actin.
Figure 1. AKT is localized in the nucleus of melanoma cellsA2058 cells were double immunostained for AKT and CREB and analyzed by confocal laser-scanning microscopy. Images are projections of one stack from the middle plane of the nucleus. (A) AKT is shown in red, CREB is shown in green, DAPI-stained nuclei are shown in blue and DIC represents differential interference contrast image. (B) Merged image of endogenous AKT and CREB. (C) Merged image of AKT and DAPI. The yellow cross in the merged panel of AKT and DAPI shows the confocal z-series reconstruction and corresponding xz and yz orthogonal planes. Confocal image and orthogonal views show that AKT immunostaining is localized in melanoma cells nuclei. (D) Co-localization map for AKT and DAPI, obtained using the Colocalization Threshold plugin for ImageJ, shows pixels with positive signals for both probes in white; scale bar, 5 μm.
Figure 2. Both phosphorylated and non-phosphorylated AKT are present in melanoma cells nucleiA2058 cells were serum starved for 24 h and then stimulated (+) or not (−) with 10% serum for 30 min. (A) Nuclear and cytoplasmic fractions were analyzed by Western blot with anti-lamin A/C or anti-β-tubulin to confirm the purity of the nuclear and cytoplasmic fractions, respectively. (B) Nuclear and cytoplasmic fractions were analyzed by Western blot with anti-p-AKT-Ser473, anti-p-AKT-Thr308 and anti-total-AKT. (C) A2058 cells were serum starved for 24 h in the presence (+) or absence (−) of the PI3K inhibitor XI (20 μM) and then stimulated with 10% serum for 30 min (+). Nuclear fractions were analyzed by Western blot with anti-p-AKT-Ser473, anti-p-AKT-Thr308 and anti-total-AKT. (B and C) Results were plotted as the mean +/− S.D., n=3. Fold change in AKT phosphorylation was normalized to the levels of total-AKT.
Figure 3. Identification of nuclear AKT binding proteins in melanoma cells nucleiA2058 cells were serum starved for 24 h and then stimulated (+) or not (−) with 10% serum for 30 min as indicated. Nuclear extracts were submitted to two-step chemical cross-linking and immunoprecipitations (IP) were performed using anti-total AKT or control IgG antibodies. Co-immunoprecipitated materials were resolved on SDS-PAGE. Coomassie blue staining of the gel revealed co-immunoprecipitated bands of approximately 42 and 200 kDa. The identified bands were excised and subjected to trypsin digestion for LC-MS/MS analysis.
Figure 4. Nuclear AKT interacts with β-actinA2058 cells were serum starved for 24 h and then stimulated (+) or not (−) with 10% serum for 30 min, as indicated. (A) Nuclear lysates were submitted to immunoprecipitation (IP) with anti-total AKT or control IgG antibodies. Cell lysates prior to immunoprecipitation were used as input. Input and co-immunoprecipitated proteins were immunoblotted (IB) for detection of total AKT and β-actin. (B) A2058 cells were double immunostained for AKT and β-actin and analyzed by confocal laser-scanning microscopy. Confocal images show maximum projection of image stacks. AKT is shown in green, β-actin is shown in red, DAPI-stained nuclei are shown in blue. Merged images are shown at higher magnification in the panels below. Reconstructed orthogonal projection is presented as viewed in the xz plane, showing co-localization of AKT with β-actin in the nucleus (yellow pixels, arrowhead); scale bar, 5 μm.
Figure 5. AKT/β-actin complex is not disturbed by inhibition of AKT phosphorylation(A) A2058 cells were serum starved for 24 h and then stimulated (+) or not (−) with 10% serum for 30 min as indicated. Nuclear fractions were immunoprecipitated (IP) with anti-total AKT or control IgG antibodies. Cell lysates prior to immunoprecipitation were used as input. Input and co-IP proteins were resolved on SDS-PAGE and immunoblotted for the detection of p-AKT Ser473, total AKT and β-actin (B). The result shown in (A) was validated by reverse IP where anti-β-actin was used for immunoprecipitation instead of anti-total AKT. (C) A2058 cells were serum starved for 24 h in the presence (+) or absence (−) of the PI3K inhibitor XI (20 μM) and then stimulated (+) or not (−) with 10% serum for 30 min. Nuclear fractions were analyzed by Western blot with anti-p-AKT Ser473, anti-total AKT and anti-β-actin. (D) A2058 cells were treated as described in C and nuclear lysates were immunoprecipitated with anti-total AKT or control IgG antibodies. Co-IP proteins were resolved on SDS-PAGE and immunoblotted for detection of p-AKT Ser473, total AKT and β-actin.
Figure 6. Nuclear AKT interacts with cofilin(A) A2058 cells were serum starved for 24 h and then stimulated (+) or not (−) with 10% serum for 30 min, as indicated. Nuclear fractions were immunoprecipitated (IP) with anti-cofilin or control IgG antibodies. Cell lysates prior to immunoprecipitation were used as input. Input and co-IP proteins were resolved on SDS-PAGE and immunoblotted for the detection of p-AKT473, total AKT, β-actin and cofilin. (B and C) A2058 cells were double immunostained for: (B) AKT (green) and Cofilin (red); (C) cofilin (green) and β-actin (red). DAPI-stained nuclei are shown in blue. Immunostained cells were analyzed by confocal laser-scanning microscopy. Images are projections of one stack from the middle plane of the nucleus. Reconstructed orthogonal projections are presented as viewed in the xz planes, showing co-localized immunostaining in the nucleus (yellow pixels, arrowhead); scale bar, 5 μm.
Figure 7. Both nuclear AKT and cofilin co-localize with active RNA Pol IIA2058 cells were double immunostained either for (A) AKT or (B) Cofilin with RNA Pol II phosphorylated at Ser2 in the CTD. AKT and Cofilin are shown in green, RNA Pol II is shown in red and DAPI-stained nuclei are shown in blue. Immunostained cells were analyzed by confocal laser-scanning microscopy. Images are projections of one stack from the middle plane of the nucleus. Reconstructed orthogonal projections are presented as viewed in the xz plane, showing co-localized immunostaining in the nucleus (yellow pixels, arrowhead); scale bar, 5 μm.
Figure 8. Schematic representation summarizing the interaction network of nuclear AKT and its predicted location at functional nuclear regions(1) AKT is translocated from the cytoplasm to the nucleus by an yet unknown mechanism; (2) cofilin bound to monomeric actin mediates the transport of actin to the nucleus; (3) In the nucleus, AKT interacts with actin/cofilin complex; (4) AKT interaction with actin/cofilin complex may be target to active Pol II phosphorylated in the CTD.
Adini,
RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development.
2003, Pubmed
Adini,
RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development.
2003,
Pubmed
Ahn,
Nuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNase.
2006,
Pubmed
Astoul,
The dynamics of protein kinase B regulation during B cell antigen receptor engagement.
1999,
Pubmed
Bavelloni,
Prohibitin 2 represents a novel nuclear AKT substrate during all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells.
2014,
Pubmed
Bellacosa,
Activation of AKT kinases in cancer: implications for therapeutic targeting.
2005,
Pubmed
Biggs,
Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1.
1999,
Pubmed
Borgatti,
Translocation of Akt/PKB to the nucleus of osteoblast-like MC3T3-E1 cells exposed to proliferative growth factors.
2000,
Pubmed
Brunel,
Two-dimensional analysis of proteins associated with heterogenous nuclear RNA in various animal cell lines.
1979,
Pubmed
Butler,
Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting.
2009,
Pubmed
Cenni,
Targeting of the Akt/PKB kinase to the actin skeleton.
2003,
Pubmed
Chen,
BRAFV600E negatively regulates the AKT pathway in melanoma cell lines.
2012,
Pubmed
Davies,
Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma.
2009,
Pubmed
Dopie,
Active maintenance of nuclear actin by importin 9 supports transcription.
2012,
Pubmed
Dunn,
A practical guide to evaluating colocalization in biological microscopy.
2011,
Pubmed
Fomproix,
An actin-myosin complex on actively transcribing genes.
2004,
Pubmed
Gounon,
Involvement of contractile proteins in the changes in consistency of oocyte nucleoplasm of the newt Pleurodeles waltlii.
1981,
Pubmed
Hers,
Akt signalling in health and disease.
2011,
Pubmed
Hofmann,
Actin is part of pre-initiation complexes and is necessary for transcription by RNA polymerase II.
2004,
Pubmed
Hu,
A role for beta-actin in RNA polymerase III transcription.
2004,
Pubmed
Hu,
Akt phosphorylates acinus and inhibits its proteolytic cleavage, preventing chromatin condensation.
2005,
Pubmed
Huang,
Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity.
2005,
Pubmed
Huang,
Effective identification of Akt interacting proteins by two-step chemical crosslinking, co-immunoprecipitation and mass spectrometry.
2013,
Pubmed
Jain,
Nuclear localized Akt enhances breast cancer stem-like cells through counter-regulation of p21(Waf1/Cip1) and p27(kip1).
2015,
Pubmed
Kikani,
"New"-clear functions of PDK1: beyond a master kinase in the cytosol?
2005,
Pubmed
Kumeta,
Nucleocytoplasmic shuttling of cytoskeletal proteins: molecular mechanism and biological significance.
2012,
Pubmed
Lee,
Non-small cell lung cancers frequently express phosphorylated Akt; an immunohistochemical study.
2002,
Pubmed
Lee,
Nuclear Akt interacts with B23/NPM and protects it from proteolytic cleavage, enhancing cell survival.
2008,
Pubmed
Leinninger,
Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons.
2004,
Pubmed
Li,
Nuclear ErbB2 enhances translation and cell growth by activating transcription of ribosomal RNA genes.
2011,
Pubmed
Machado,
Characterisation of NF-kappa B complexes in Theileria parva-transformedT cells.
2000,
Pubmed
Martelli,
The emerging multiple roles of nuclear Akt.
2012,
Pubmed
Maundrell,
Characterization of pre-messenger-RNA-containing nuclear ribonucleoprotein particles from avian erythroblasts.
1979,
Pubmed
Meier,
Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase Bbeta.
1997,
Pubmed
Migocka-Patrzałek,
β- and γ-Actins in the nucleus of human melanoma A375 cells.
2015,
Pubmed
Mundi,
AKT in cancer: new molecular insights and advances in drug development.
2016,
Pubmed
Neri,
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate.
2002,
Pubmed
Neri,
Increase in nuclear phosphatidylinositol 3-kinase activity and phosphatidylinositol (3,4,5) trisphosphate synthesis precede PKC-zeta translocation to the nucleus of NGF-treated PC12 cells.
1999,
Pubmed
Nicholson,
Autocrine signalling through erbB receptors promotes constitutive activation of protein kinase B/Akt in breast cancer cell lines.
2003,
Pubmed
Obrdlik,
The histone acetyltransferase PCAF associates with actin and hnRNP U for RNA polymerase II transcription.
2008,
Pubmed
Obrdlik,
The F-actin severing protein cofilin-1 is required for RNA polymerase II transcription elongation.
2011,
Pubmed
Pekarsky,
Tcl1 enhances Akt kinase activity and mediates its nuclear translocation.
2000,
Pubmed
Percipalle,
An actin-ribonucleoprotein interaction is involved in transcription by RNA polymerase II.
2003,
Pubmed
Percipalle,
Nuclear actin is associated with a specific subset of hnRNP A/B-type proteins.
2002,
Pubmed
Percipalle,
Co-transcriptional nuclear actin dynamics.
2013,
Pubmed
Philimonenko,
Nuclear actin and myosin I are required for RNA polymerase I transcription.
2004,
Pubmed
Risso,
Akt/PKB: one kinase, many modifications.
2015,
Pubmed
Rosner,
Detection of cytoplasmic and nuclear functions of mTOR by fractionation.
2012,
Pubmed
Saji,
Akt1 contains a functional leucine-rich nuclear export sequence.
2005,
Pubmed
Salinas,
Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells.
2000,
Pubmed
Slipicevic,
Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcome.
2005,
Pubmed
Trotman,
Identification of a tumour suppressor network opposing nuclear Akt function.
2006,
Pubmed
Van de Sande,
High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB.
2005,
Pubmed
Vandermoere,
Proteomics exploration reveals that actin is a signaling target of the kinase Akt.
2007,
Pubmed
Vasko,
Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer.
2004,
Pubmed
Viita,
From Cytoskeleton to Gene Expression: Actin in the Nucleus.
2017,
Pubmed
Wang,
AKT can be activated in the nucleus.
2006,
Pubmed
Xie,
Power of PTEN/AKT: Molecular switch between tumor suppressors and oncogenes.
2016,
Pubmed
Xuan Nguyen,
Akt phosphorylation is essential for nuclear translocation and retention in NGF-stimulated PC12 cells.
2006,
Pubmed
Zhang,
PEAKS DB: de novo sequencing assisted database search for sensitive and accurate peptide identification.
2012,
Pubmed
Zheng,
Nuclear actin and actin-binding proteins in the regulation of transcription and gene expression.
2009,
Pubmed